Trial Profile

A Phase 2 Open-Label Study of the Pharmacokinetics (PK) and Safety of HTX-011 Administered Postpartum to Women Undergoing a Planned Caesarean Section

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 22 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bupivacaine/meloxicam (Primary) ; Ibuprofen; Paracetamol
Indications Postoperative pain
Focus Pharmacokinetics
Sponsors Heron Therapeutics

Most Recent Events

16 May 2022 According to a Heron Therapeutics Media Release, interim results at the Society for Obstetric Anesthesia and Perinatology (SOAP) 54th Annual Meeting
16 May 2022 Interim results published in the Heron Therapeutics Media Release
11 Mar 2022 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com